Results of the meeting of the Interdisciplinary Expert Council on an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders

The reduction in sex hormone levels during the menopausal period substantially impacts patients’ quality of life and serves as a significant risk factor for psycho-emotional disorders. Current clinical guidelines from both Russian and international sources recognize menopausal hormone therapy (MHT) as the primary method for addressing menopausal disorders. However, selecting dosage forms tailored to the patient’s comorbidities and overall health status is essential. In 2026, the Russian Association of Obstetricians and Gynecologists, the Interdisciplinary Association of Specialists in Healthy Aging and Anti-Aging Medicine, and the Russian Society for the Study of Headache established an interdisciplinary council to implement an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders. The objectives of the expert council included discussing contemporary management strategies for peri- and postmenopausal women and optimizing the application of MHT in complex clinical cases. Additionally, the council aimed to enhance scientific methodologies and devise algorithms for managing patients presenting with menopausal symptoms due to estrogen deficiency, alongside neurological and psycho-emotional disorders. The collaborative efforts of the experts culminated in a consensus document that outlines key principles for the administration of MHT to women with psycho-emotional disorders and somatic comorbidities during the peri- and postmenopausal stages.